Lessons from India's jab rollout 17 published : 29 Jan 2021 at 04:00 17 In just 12 days after India launched its Covid-19 vaccination programme on Jan 16 -- touted as the world's largest coronavirus jab rollout -- more than 2.3 million healthcare workers have been inoculated against the virus. In Phase I of the drive, India plans to vaccinate some 30 million healthcare and frontline workers. For India, such large-scale vaccinations are not new. Every year, 27 million infants are immunised against 12 diseases. The government's polio immunisation drive, which successfully eradicated the disease from India, has even set the global standard for such programmes. Worth noting is the fact that the two Covid-19 vaccines authorised for emergency use in the country are domestically manufactured -- the AstraZeneca/Oxford-developed Covishield, which is produced by the Serum Institute of India; and Covaxin, developed indigenously by Bharat Biotech and the Indian Council for Medical Research.